Carl is Assistant Vice Principal (Strategy & Resources) at the University of Glasgow, and Professor of Translational Immunology & Director for Innovation, Engagement & Enterprise in the School of Infection & Immunity.
His research is currently focused on understanding immunopathogenesis of disease (i.e., Rheumatoid Arthritis, Osteoarthritis & Multiple Myeloma) and translating this knowledge into viable therapeutic agents for patients. He leads a Translational Immunology programme that provides the critical interface between clinical and basic science, with a specific focus on precision medicine. In parallel, he is also the Director of the GLAZgo Discovery Centre and the Glasgow-Lilly Centre, strategic collaborations between the University of Glasgow and AstraZeneca, and Eli-Lilly respectively. Both of which are aimed at driving innovative academic/industry research. Carl has published widely in the areas of immunobiology and rheumatology. He is a Chair/Deputy Chair or member of various Research Advisory committees & grant review Panels.